Cargando…

Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes

Human papillomaviruses (HPVs) are causative agents in around 5% of all cancers, including cervical and oropharyngeal. A feature of HPV cancers is their better clinical outcome compared with non-HPV anatomical counterparts. In turn, the presence of E2 predicts a better clinical outcome in HPV-positiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fontan, Christian T., Das, Dipon, Bristol, Molly L., James, Claire D., Wang, Xu, Lohner, Hannah, Atfi, Azeddine, Morgan, Iain M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729257/ https://www.ncbi.nlm.nih.gov/pubmed/33298572 http://dx.doi.org/10.1128/mSphere.00981-20

Ejemplares similares

Human Papillomavirus 16 E6 and E7 Synergistically Repress Innate Immune Gene Transcription
por: James, Claire D., et al.
Publicado: (2020)

Interaction with TopBP1 Is Required for Human Papillomavirus 16 E2 Plasmid Segregation/Retention Function during Mitosis
por: Prabhakar, Apurva T., et al.
Publicado: (2022)

A Critical Role for p53 during the HPV16 Life Cycle
por: Fontan, Christian T., et al.
Publicado: (2022)

Werner Helicase Control of Human Papillomavirus 16 E1-E2 DNA Replication Is Regulated by SIRT1 Deacetylation
por: Das, Dipon, et al.
Publicado: (2019)

Correction for Morgan et al., “Werner Helicase Control of Human Papillomavirus 16 E1-E2 DNA Replication Is Regulated by SIRT1 Deacetylation”
por: Das, Dipon, et al.
Publicado: (2019)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

Variants of human papillomaviruses 16 (HPV16) in Uigur women in Xinjiang, China
por: He, Hongchang, et al.
Publicado: (2016)

An oral keratinocyte life cycle model identifies novel host genome regulation by human papillomavirus 16 relevant to HPV positive head and neck cancer
por: Evans, Michael R., et al.
Publicado: (2017)

Correction: An oral keratinocyte life cycle model identifies novel host genome regulation by human papillomavirus 16 relevant to HPV positive head and neck cancer
por: Evans, Michael R., et al.
Publicado: (2019)

Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens
por: Lee, Sin Hang, et al.
Publicado: (2009)

Human papillomavirus (HPV) 16 infection is not detected in rectal carcinoma
por: Martins, Sandra F., et al.
Publicado: (2020)

Human Papillomavirus 16 E2 Interaction with TopBP1 Is Required for E2 and Viral Genome Stability during the Viral Life Cycle
por: Prabhakar, Apurva T., et al.
Publicado: (2023)

Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women
por: Ramanakumar, Agnihotram V, et al.
Publicado: (2010)

Antibodies against human papillomavirus type 16 (HPV-16) and conjunctival squamous cell neoplasia in Uganda
por: Waddell, K, et al.
Publicado: (2003)

HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation
por: Yu, Lulu, et al.
Publicado: (2022)

The transcriptional regulator gene E2 of the Human Papillomavirus (HPV) 16 influences the radiosensitivity of cervical keratinocytes
por: Lindel, Katja, et al.
Publicado: (2012)

Anti-HPV16 Antibody Titers Prior to an Incident Cervical HPV16/31 Infection
por: Gradissimo, Ana, et al.
Publicado: (2021)

HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial
por: Tsang, Sabrina H., et al.
Publicado: (2022)

In silico prediction of structural changes in human papillomavirus type 16 (HPV16) E6 oncoprotein and its variants
por: Rodríguez-Ruiz, Hugo Alberto, et al.
Publicado: (2019)

Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors
por: Damm, Oliver, et al.
Publicado: (2009)

Activating the DNA Damage Response and Suppressing Innate Immunity: Human Papillomaviruses Walk the Line
por: James, Claire D., et al.
Publicado: (2020)

Werner Syndrome Protein (WRN) Regulates Cell Proliferation and the Human Papillomavirus 16 Life Cycle during Epithelial Differentiation
por: James, Claire D., et al.
Publicado: (2020)

Why Human Papillomaviruses Activate the DNA Damage Response (DDR) and How Cellular and Viral Replication Persists in the Presence of DDR Signaling
por: Bristol, Molly L., et al.
Publicado: (2017)

CK2 Phosphorylation of Human Papillomavirus 16 E2 on Serine 23 Promotes Interaction with TopBP1 and Is Critical for E2 Interaction with Mitotic Chromatin and the Viral Life Cycle
por: Prabhakar, Apurva T., et al.
Publicado: (2021)

A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancer
por: Jiang, Pengfei, et al.
Publicado: (2018)

HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection
por: Beachler, Daniel C., et al.
Publicado: (2016)

Prevalence of HPV 16 and HPV 18 Lineages in Galicia, Spain
por: Pérez, Sonia, et al.
Publicado: (2014)

Interaction of HPV16 and Cutaneous HPV in Head and Neck Cancer
por: Al-Soneidar, Walid A., et al.
Publicado: (2022)

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
por: van Poelgeest, Mariette I E, et al.
Publicado: (2013)

Prevalence of Human Papillomavirus (HPV)-16 in Different Dental Infections in the Lebanese Population
por: Khalil, Wael, et al.
Publicado: (2023)

Folate Repletion after Deficiency Induces Irreversible Genomic and Transcriptional Changes in Human Papillomavirus Type 16 (HPV16)-Immortalized Human Keratinocytes
por: Savini, Claudia, et al.
Publicado: (2019)

DNA Damage Reduces the Quality, but Not the Quantity of Human Papillomavirus 16 E1 and E2 DNA Replication
por: Bristol, Molly L., et al.
Publicado: (2016)

More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population
por: Marais, Dianne J, et al.
Publicado: (2006)

p16 in HPV-associated cancers
por: Munger, Karl, et al.
Publicado: (2013)

Transcriptional Repression of E-Cadherin by Human Papillomavirus Type 16 E6
por: D'Costa, Zarina J., et al.
Publicado: (2012)

Dynamic response of HPV16/anti-HPV16 pairs with unbinding events studied by atomic force microscopy
por: Lin, Shiming, et al.
Publicado: (2016)

Deep Sequencing of HPV16 E6 Region Reveals Unique Mutation Pattern of HPV16 and Predicts Cervical Cancer
por: Ai, Wenchao, et al.
Publicado: (2022)

SOX2 as a New Regulator of HPV16 Transcription
por: Martínez-Ramírez, Imelda, et al.
Publicado: (2017)

Diversity of cervicovaginal human papillomavirus (HPV) genotypes and naturally occurring E6/E7 DNA polymorphisms of HPV-16 in Ghana
por: Kaba, Gladys, et al.
Publicado: (2023)

Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody
por: Peng, Shiwen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_45b50qojmr6aa44diuf8kresvj